We examined the cellular and ionic mechanism for QT prolongation and subsequent Torsade de Pointes (TdP) and the effect of verapamil under conditions mimicking KCNQ1 (I Ks gene) defect linked to acquired long QT syndrome (LQTS). BACKGROUND Agents with an I Kr -blocking effect often induce marked QT prolongation in patients with acquired LQTS. Previous reports demonstrated a relationship between subclinical mutations in cardiac K ϩ channel genes and a risk of drug-induced TdP.
The long QT syndrome (LQTS) is characterized by a prolongation of ventricular repolarization and recurrent episodes of atypical polymorphic ventricular tachycardia known as Torsade de Pointes (TdP) leading to sudden cardiac death (1) (2) (3) . The molecular basis of congenital LQTS is attributed to defects in several ion channel genes encoding delayed rectifier K ϩ or Na ϩ currents. On the other hand, agents that block rapidly activating delayed rectifier potassium current (I Kr ) often induce marked QT prolongation with an inverted T wave in patients with acquired LQTS. Recent studies indicate that some cases of drug-induced LQTS can be associated with silent mutations and common polymorphism in genes responsible for the congenital LQTS (4), such as KCNQ1 encoding slowly activating delayed rectifier potassium currents (I Ks ) (5-7). However, it remains unclear why subclinical I Ks dysfunction is a risk of drug-induced LQTS.
Both early afterdepolarization (EAD)-induced triggered activity and increased dispersion of repolarization have been suggested as important in the genesis of ventricular arrhythmias in congenital and acquired LQTS. Moreover, verapamil, an L-type Ca 2ϩ channel blocker, suppressed EADs and TdP in patients with LQTS (8, 9) . In the present study, we hypothesized that: 1) addition of I Kr block to I Ks dysfunction markedly prolongs action potential duration (APD) and induces TdP by producing EADs and/or increases transmural dispersion of repolarization (TDR); and 2) verapamil suppresses TdP by preventing EADs and decreasing TDR. In arterially perfused feline left ventricular wedge preparations, we demonstrated that subclinical I Ks dysfunction, mimicking KCNQ1 defect, could be a risk of drug-induced TdP, and verapamil successfully suppressed TdP in the model of acquired LQTS.
METHODS
Arterially perfused wedge preparations and electrophysiologic recordings. All animal care procedures were in accordance with the position of the American Heart Association research animal use (November 11, 1984) . The methods used for isolation, perfusion, and recording of transmembrane activity from the arterially perfused feline left ventricle have been detailed in a previous study (10) and are similar to methods reported using canine or rabbit wedge preparations (11) (12) (13) (14) (15) . Briefly, a transmural wedge was dissected from the anterior wall of the left ventricle, cannulated via the left descending coronary artery (or the first branch of the left circumflex), and placed in a small tissue bath arterially perfused with Tyrode's solution. The temperature was maintained at 37 Ϯ 1°C and perfusion pressure maintained between 40 and 60 mm Hg. Ventricular wedges were stimulated with bipolar electrodes applied to the endocardial surface. We recorded a transmural electrocardiogram (ECG) (epicardial, positive pole) using Ag-AgCl electrodes, and transmembrane action potentials (APs) simultaneously from the epicardium, midmyocardium (M), and endomyocardium using three separate intracellular floating microelectrodes. The epicardial and endocardial APs were recorded from the epicardial and endocardial surfaces, respectively, at positions approximating the transmural axis of the ECG. The M-cell's AP was recorded from the transmural surface, mainly at the subendocardium, along the same axis.
An I Kr blocker, E-4031 1 mol/l, was used in control condition (n ϭ 5) or under condition with I Ks suppression by chromanol 293B 10 mol/l, mimicking KCNQ1 defect (n ϭ 10). The effects of an L-type Ca 2ϩ channel blocker, verapamil, were evaluated at 0.1, 1, 2.5, and 5 mol/l under the I Ks and I Kr suppression (acquired LQTS condition). Epinephrine 0.5 mol/l was used to mimic increased sympathetic activity in the absence and presence of verapamil under the acquired LQTS condition. The spontaneous or epinephrine-induced EADs and subsequent TdP were evaluated under each set of conditions.
Data using E-4031, 293B, 293B ϩ E-4031, and additional verapamil on top of 293B ϩ E-4031 were collected for a period of 30 min starting 30 min after applying the above compounds to the perfusion. The APD was measured at 90% repolarization (APD 90 ). The TDR was defined as the difference between the longest and shortest repolarization times (activation time ϩ APD 90 ) of the APs recorded across the wall. The QT interval was defined as the time interval between the QRS onset and the point at which the line of maximal downslope of the positive T wave and the line of the maximal upslope of the negative T wave crossed the baseline. Whole-cell patch-clamp experiments. Epicardial, M, and endocardial cells isolated from the feline left ventricle were voltage-clamped using whole-cell configuration of the patch-clamp technique (16) In all current measurements, nisoldipine (0.4 mol/l) was added to normal Tyrode's solution to abolish I Ca,L . The cell membrane capacitance (C m ) was calculated for each cell by fitting the single exponential function to the decay of the capacitive transient elicited by a 5-mV step hyperpolarization applied from a holding potential of Ϫ50 mV (17) . Simulation study. Isolated epicardial, M, and endocardial cells were simulated using a Luo-Rudy dynamic cell model modified by varying the maximum conductance (density) of I Kr and I Ks (G Kr and G Ks ) as described previously (18) , in which the G Ks /G Kr in the epicardial, M, and endocardial cells were 23, 17, and 19, respectively. The transient outward potassium current (I to ) was incorporated into the model using the formulation of Dumaine et al. (19) , in which the maximum conductance of I to (G to ) was set to 0.5, 0.25, and 0.05 mS/F in the epicardial, M, and endocardial cells, respectively. Statistics. Statistical analysis of the data was performed with a Student t test for paired data or analysis of variance coupled with Bonferroni's test, as appropriate. Data are expressed as mean values Ϯ SD except for those shown in the figures, which are expressed as mean Ϯ SEM. Significance was defined as a value of p Ͻ 0.05.
RESULTS
The QT interval, APD, and TDR under an acquired LQTS condition with or without epinephrine. Figure 1 shows transmembrane activity recorded simultaneously from the epicardium, M, and endocardium together with a transmural ECG at a basic cycle length (BCL) of 2,000 ms. E-4031 (1 mol/l) alone significantly, but homogenously, prolonged APD of the three regions, causing no major change in TDR (Fig. 1B) . Chromanol 293B (10 mol/l) alone did not significantly increase the QT interval, APD of the three regions, and TDR (Fig. 1C) . The additional E-4031 to 293B, mimicking acquired LQTS, preferentially prolonged epicardial APD, thus dramatically increased QT interval and TDR (Fig. 1D ). Epinephrine infusion (0.5 mol/l) further prolonged epicardial APD associated with induction of EADs, but did not prolong M or endocardial APD, resulting in further QT prolongation and increasing TDR (Fig. 1E ).
The composite data of the QT interval, APD 90 of the epicardium, M, and endocardium, and TDR at a BCL of 2,000 ms are shown in Table 1 . E-4031 under control significantly, but homogeneously, prolonged APD 90 , resulting in neither change of TDR nor induction of arrhythmia. Chromanol 293B under control did not significantly increase APD 90 of the three regions, resulting in no major change in QT interval and TDR. Whereas additional E-4031 to 293B markedly prolonged QT interval as evidenced by preferential prolongation of the epicardial APD 90 compared with M and endocardial APD 90 , thus dramatically increased TDR. Epinephrine further prolonged the epicardial APD 90, but shortened the M region APD 90 , resulting in further prolongation of the QT interval and increasing TDR.
Neither E-4031 alone nor 293B alone produced any EADs or TdP. However, additional E-4031 to 293B (acquired LQTS condition) induced spontaneous EADs from the epicardium in 5 of 10 preparations, including two preparations with spontaneous TdP (Fig. 2) , but not from the M or endocardium. Further epinephrine infusion (n ϭ 8) induced EADs from the epicardium in all preparations, including four preparations with subsequent TdP, but EADs from the M region were seen in only one preparation. Effect of verapamil on the QT interval, APD, TDR, and induction of arrhythmias under an acquired LQTS condition. Under the acquired LQTS condition, verapamil dose-dependently (0.1 to 5 mol/l) abbreviated APD of APD 90 ϭ action potential duration at 90% repolarization; Endo ϭ endocardium; Epi ϭ epicardium; Epine ϭ epinephrine; I ks ϭ slowly activating delayed rectifier potassium current; I kr ϭ rapidly activating delayed rectifier potassium current; M ϭ mid-myocardium; QT ϭ QT interval; TDR ϭ transmural dispersion of repolarization; Verap ϭ verapamil. the epicardial and M regions as well as the QT interval (Fig. 3A) . Figure 3B As shown in Figure 1F , 2.5-mol/l verapamil preferentially abbreviated the epicardial APD 90 rather than the M or endocardium, thus significantly abbreviated QT interval and TDR. Moreover, verapamil completely prevented the influence of epinephrine in inducing EADs and TdP as well as increasing the epicardial APD 90 , QT interval, and TDR (Fig. 1G) . The composite data of the effect of verapamil on the QT interval, APD, and TDR with or without epinephrine are shown in Table 1 . Thus, verapamil totally suppressed EADs and TdP under the acquired LQTS condition with or without epinephrine. Measurement of I Kr and I Ks in epicardial, M, and endocardial cells. Figure 4A represents the dosedependent inhibition of I Ks by 293B in an epicardial cell. Figure 4B illustrates the concentration-response relation- There are no significant differences in IC 50 and n H values among the epicardial, M, and endocardial cells (analysis of variance with Bonferroni's test), thus indicating that I Ks in these three cell types represents a similar sensitivity to inhibition by chromanol 293B. Figure 5 represents the sensitivity of I K to blockers of I Kr and I Ks (E-4031 and 293B, respectively). After the I K reached a practically steady level (control, trace 1), application of E-4031 (3 mol/l) markedly reduced the amplitude of I K tail current (trace 2), and further addition of 293B (30 mol/l) almost completely abolished the I K tail current (trace 3). Table 2 summarizes densities of I Kr and I Ks in the epicardial, M, and endocardial cells, determined as E-4031-and 293B-sensitive tail currents normalized with reference to C m . In each cell type, the density of I Ks was significantly smaller than that of I Kr . The density of I Kr was almost equivalent among the three cell types, whereas I Ks density was significantly smaller in M cells compared with that in the epicardial and endocardial cells. Computer simulations. To understand why EAD developed from the epicardium under the acquired LQTS 
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Cellular and Ionic Mechanism of Acquired LQTS condition, we simulated APs of the three cell types using a Luo-Rudy model at a BCL of 2,000 ms. As shown in Figure  6A , the epicardial APD was shorter than the M cells under the control condition (dotted line). However, suppression of both I Kr and I Ks (70% and 80%, respectively) (solid line), simulating the condition of acquired LQTS, developed EAD (arrow) from the epicardial cell but not from M or endocardial cells. Moreover, Figure 6B shows that the reactivation of Ca 2ϩ current through the L-type channel (I Ca,L ) was responsible for the development of epicardial EAD under the acquired LQTS condition. Furthermore, a decrease in I to density changed by G to from 0.5 to 0.05 
DISCUSSION
Genetic and ionic substrates of acquired LQTS. Acquired QT prolongation and TdP arrhythmias usually require multiple risk factors, such as bradycardia, hypokalemia, female gender, and mostly agents with an I Krblocking effect. Recent genetic studies suggest some forms of acquired LQTS can be associated with silent mutations in the LQTS-related genes (4), such as KCNQ1 encoding I Ks (so-called forme fruste type of congenital LQTS) (5-7). Roden (20) hypothesized "reduced repolarization reserve" as a potential mechanism underlying susceptibility to druginduced LQTS. According to his hypothesis, I Ks dysfunction could be potentially compensated by other K ϩ currents, mainly I Kr , thereby the repolarization defect is tolerated, and agents with I Kr block could induce acquired QT prolongation and TdP.
Vos et al. (21-23) suggested a high incidence of EADs and TdP by d-sotalol in dogs with chronic complete atrioventricular block as a result of a significant downregulation of I Ks and I Kr . Moreover, other experimental studies using canine and rabbit wedge showed combined I Ks and I Kr block caused a high incidence of EADs most likely arising from the epicardium (14, 15) . Burashnikov and Antzelevitch (24) suggested that the abundant I Ks in the epicardium and endocardium compared with the M region under normal conditions contributed to the increase in TDR but protected against development of EADs in the epicardium and endocardium in dogs. Thus, I Ks is critically important for the repolarization reserve in the epicardium and endocardium.
Although I Ks in the feline heart is far smaller than that in other species (25, 26) , our result from a whole-cell patchclamp study suggested that a 10-mol/l 293B used in the wedge preparation reduced about 70% of I Ks in the three cell types, which is consistent with degree of I Ks blockade caused by a silent mutation or common polymorphism in human KCNQ1 gene (6, 7) . We also showed that I Kr block with E-4031 in control conditions prolonged the QT interval but did not increase TDR and developed neither EADs nor TdP. However, combined I Kr block with 293B further prolonged the QT interval and inverted T wave, which, in turn, increased TDR and induced EADs and TdP. There- fore, the feline heart is appropriate for a model of forme fruste LQTS. Our data also suggested that subclinical I Ks dysfunction may become a genetic substrate, and additional I Kr suppression may unmask marked QT prolongation and TdP in acquired form of LQTS. Role of I Ca,L in increasing TDR and inducing EADs and TdP in acquired LQTS. Several clinical and experimental studies have suggested that EADs and triggered activity were important in the genesis of QT prolongation and TdP in LQTS (8, 9, (11) (12) (13) (14) (15) (22) (23) (24) . Induction of EADs generally requires an initiation or conditioning phase controlled by the sum of membrane currents present at the plateau AP (inward depolarization current and outward repolarization current). January and Riddle (27) suggested that the timeand voltage-dependent I Ca,L within its "window" was important in the induction and block of EADs. Luo and Rudy (28) suggested that EADs resulted from a secondary activation of the I Ca,L during the plateau of AP. However, the mechanism responsible for a high incidence of EADs (especially from the epicardium) and subsequent TdP under conditions of severely eliminated outward K ϩ current, mimicking acquired LQTS, has not been mechanistically defined.
Our data indicate that accentuation of I Ca,L during the AP plateau preferentially prolonged APD and triggered EADs in the epicardium. This was based on the effect of verapamil on the epicardium. However, it is still unclear whether a larger I Ca,L in the epicardial cell compared with the M or endocardial cells contributed to the development of EADs. Recently, Bányász et al. (29) reported in their AP voltage clamp experiments that the epicardial cell had a pool of Ca 2ϩ channels sufficient for a second activation, whereas the endocardial cells did not. Cordeiro et al. (30) also noted that the presence of spike-and-dome AP waveform in the epicardial cells resulted in a greater magnitude of I Ca,L . Moreover, several simulation studies demonstrated a strong coupling between I Ca,L and I to (31, 32) . Our simulation study also suggested that larger I to in the epicardial cell caused larger I Ca,L , developing EADs under the acquired LQTS condition. In the feline left ventricle, it has been reported that I to is larger in the epicardium compared with the endocardium (33) . Therefore, larger I Ca,L secondary to I to -mediated spike-and-dome AP configuration in the epicardial cell might be responsible for the high incidence of EADs from the epicardium. This does not necessarily exclude the possible mechanisms of other ionic currents such as I NaCa and Ca 2ϩ release from sarcoplasmic reticulum, which may contribute to the prolonged AP as well as to the development of EADs under calcium-loading conditions (34) . Effects of catecholamines and verapamil in acquired LQTS. Treatment of drug-induced TdP begins with immediate withdrawal of any potential drugs and risk factors. Sanguinetti et al. (35) suggested that an increase of heart rate by isoproterenol was an effective therapeutic strategy in patients with acquired LQTS, because beta-adrenergic stimulation with isoproterenol abbreviates repolarization not only by increasing heart rate, but also by directly increasing the magnitude of I Ks . However, our experimental data shows that epinephrine further prolonged APD in the epicardium and induced EADs and TdP probably due to augmentation of I Ca,L in the acquired LQTS condition. Thus, beta-adrenergic stimulation could be arrhythmogenic even in conditions of acquired LQTS when subclinical I Ks dysfunction is present and heart rate is not fully increased.
Cosio et al. (8) used intravenous verapamil to treat three patients with TdP during an atrioventricular block. Shimizu et al. (9) reported that verapamil suppressed spontaneous or epinephrine-induced EADs and TdP in patients with congenital LQTS. Experimentally, Kimura et al. (36) reported that verapamil (2 mol/l) suppressed cocaineinduced EADs in the myocytes isolated from feline left ventricle. Taken together with the data in the present study, I Ca,L block with verapamil may be a therapeutic choice for TdP in patients with acquired LQTS as well as congenital LQTS. Study limitations. We assumed the activity recorded from the cut surface of the perfused wedge preparation represented cells within the respective layers of the wall throughout the wedge. Such validation was provided in previous studies that used the wedge preparation (10 -15) .
Pharmacologic block of I Ks with 293B is not a complete surrogate for KCNQ1 defect. However, our feline model closely mimicked the degree of I Ks inhibition and pharmacologic features of acquired LQTS. Therefore, we believe these qualitative similarities validate 293B as a surrogate for forme fruste LQTS.
We simulated APs of the three cell types using a Luo-Rudy model, but it does not completely represent feline ventricular APs. However, the phenomenon that EAD frequently developed from the epicardium under the acquired LQTS condition was observed not only in cats but also in dogs and rabbits (14, 15) ; thus, this simulation may support our speculation about the mechanism of this phenomenon.
Finally, the concentration of verapamil mainly used in this study (2.5 mol/l ϭ 1,250 ng/ml) was considerably higher than a typical clinical dose. However, verapamil was effective in suppressing EADs and decreasing TDR even at the lowest dose used in this study (0.1 mol/l ϭ 50 ng/ml), which is close to plasma concentration of verapamil after a 5-mg bolus injection (below 200 ng/ml).
